• Linoleic Acid (C18:2): Technical Guide for In Vitro Assays

  2026-06-29

  Linoleic Acid (C18:2(9Z,12Z), SKU C3108) is an essential fatty acid widely used for modeling oxidative stress, membrane fluidity, and nutritional deficiency in cell and animal research. It is not suitable for water-based protocols or workflows requiring long-term stock solution stability. Researchers should follow product-specific handling and preparation guidelines to ensure reproducibility and optimal assay performance.

• 2',7'-Dichlorofluorescein Diacetate Probe: Workflow, Tips &

  2026-06-29

  2',7'-Dichlorofluorescein diacetate enables sensitive, quantitative intracellular ROS detection, powering robust oxidative stress assays in cancer and drug discovery. This guide distills best practices, workflow improvements, and troubleshooting insights for maximizing assay reliability and reproducibility with this versatile fluorescent ROS probe.

• Trifluoperazine 2HCl: Unlocking Dopamine & Immune Pathways

  2026-06-28

  This thought-leadership article explores how Trifluoperazine 2HCl, a potent dopamine D2 receptor inhibitor, is catalyzing a paradigm shift in translational research by bridging dopaminergic signaling and innate immunity. Integrating mechanistic insights with strategic recommendations, we examine the latest evidence for phenothiazines’ dual role in neurological disorder research and macrophage-driven host defense, offering actionable guidance for researchers charting new territory in neuropharmacology, immunology, and beyond.

• Sex-Selective Hedgehog Pathway Modulation: SAG in Translatio

  2026-06-27

  Explore the mechanistic foundations and translational guidance for using Smoothened Agonist (SAG) as a precision tool for Hedgehog pathway modulation, with a focus on sex-dependent immune responses and neuroregeneration in demyelinating disease models. This article provides actionable insight for researchers seeking to strategically deploy SAG in advanced experimental workflows, highlighting both the biological rationale and key protocol parameters.

• CX-5461 Induces DNA Damage and Mitotic Catastrophe in Cervic

  2026-06-26

  The referenced study demonstrates that CX-5461, a selective RNA polymerase I inhibitor, suppresses cervical cancer cell growth by inducing DNA damage and mitotic catastrophe, while sensitizing cells to cisplatin. These findings provide mechanistic insight and support for targeting ribosome biogenesis as a therapeutic strategy in both primary and platinum-resistant cervical cancer.

• HyperScribe T7 Kit Plus: Benchmarking mRNA Rescue for Rare G

  2026-06-26

  Explore how the HyperScribe T7 High Yield RNA Synthesis Kit Plus empowers researchers to set new standards in in vitro mRNA synthesis for rare genetic disease models. This article offers a comparative, evidence-based perspective on T7 polymerase-driven RNA workflows—distinct from existing guides.

• CD40–STING–TRAF2 Axis Drives B Cell Activation in ESCC TLS

  2026-06-25

  This study elucidates how competitive binding of CD40 and STING with TRAF2 orchestrates IRF4-mediated B cell activation within tertiary lymphoid structures in esophageal squamous cell carcinoma (ESCC). These insights reveal new mechanistic pathways for antitumor immunity and open avenues for biomarker and therapeutic development in cancer immunotherapy research.

• Degarelix Acetate: Advanced Protocols for GnRH Receptor Anta

  2026-06-25

  Degarelix acetate empowers prostate cancer and endocrine research with precise, rapid, and sustained GnRH receptor antagonism. This article details experimental workflows, troubleshooting strategies, and real-world applications, highlighting innovations from recent synthesis studies and APExBIO’s robust supply standards.

• Caspase-3/7 Inhibitor I: Selectivity and Application in Apop

  2026-06-24

  Caspase-3/7 Inhibitor I is a cell-permeable, reversible caspase-7 inhibitor with nanomolar potency and high selectivity for caspase-3/7 over other caspases. Its effectiveness in blocking apoptosis is validated in diverse cellular models, making it a benchmark tool for dissecting caspase-dependent pathways.

• Trifluoperazine 2HCl: Reliable Dopamine D2 Inhibitor for Lab

  2026-06-23

  This article addresses common experimental challenges in cell viability, proliferation, and cytotoxicity assays, providing scenario-driven guidance on leveraging Trifluoperazine 2HCl (SKU B1397) for robust dopaminergic signaling pathway research. By integrating literature-backed protocol advice and quantitative data, researchers can improve reproducibility and sensitivity in neuropharmacology and immunology workflows using this high-quality compound.

• FXR Protein Phase Separation Drives β-Coronavirus Replicatio

  2026-06-23

  This study uncovers how fragile X–related (FXR) proteins undergo liquid–liquid phase separation (LLPS) to cluster double-membrane vesicles (DMVs)—key replication organelles—in β-coronavirus-infected cells. The findings clarify a critical host-viral interaction that enables efficient viral RNA synthesis, offering new insights into coronavirus replication mechanisms.

• Antifungal Imidazoles Inhibit CpAdhE in Cryptosporidium parv

  2026-06-22

  This study provides the first biochemical characterization of the bifunctional aldehyde/alcohol dehydrogenase (CpAdhE) in Cryptosporidium parvum, identifying antifungal imidazoles as potent, low micromolar inhibitors of the enzyme. These findings highlight CpAdhE as a promising drug target for anti-cryptosporidial therapy and demonstrate the value of targeted compound library screening in neglected parasitic diseases.

• Self-Adaptive Nanocarriers Enable Deep Tumor Penetration in

  2026-06-22

  This article examines a 2025 ACS Nano study introducing a dual pH/ROS-responsive nanocarrier system designed to overcome the formidable physiological barriers of pancreatic tumors. The research demonstrates how self-adaptive drug delivery can enhance chemotherapeutic penetration and efficacy, with implications for improved oxidative stress assessment protocols.

• 3-Methyladenine: Strategic Insights for Autophagy & Cell Dea

  2026-06-21

  Explore how 3-Methyladenine empowers translational researchers to dissect autophagy mechanisms, unlock nuances in cell death pathways, and advance therapeutic discovery. This article uniquely bridges mechanistic insight with actionable guidance, contextualizing recent findings and offering workflow strategies beyond standard reagent guides.

• HDAC Inhibitors Suppress NUT Carcinoma via Chromatin Remodel

  2026-06-20

  Shiota et al. conducted a high-throughput chemical screen revealing that diverse histone deacetylase (HDAC) inhibitors robustly repress NUT function, disrupting oncogenic chromatin megadomains in NUT carcinoma. Their findings illuminate new epigenetic vulnerabilities in this aggressive cancer, providing a foundation for therapeutic strategies targeting chromatin dynamics.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page